Business Wire India SLB (NYSE:SLB) will hold a conference call on April 24, 2026, to discuss the results for the…
Read MoreBusiness Micro
News Stories
Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting
Business Wire India Spring is in full swing at the “World’s Most Famous Building.” The Empire State Building (ESB) today…
Read MoreAndersen Consulting Enters Collaboration Agreement with Solutia
Business Wire India Andersen Consulting expands its presence in Spain through a Collaboration Agreement with Solutia, a firm specializing in…
Read MoreCSG Named a Leader in the Gartner® Magic Quadrant™ for Customer Journey Analytics & Orchestration
Business Wire India Rising customer expectations for connected, relevant, and effortless interactions are making journey analytics and orchestration critical to…
Read MoreIndia: The Up-and-Coming Solar Market
Business Wire India Solar energy expansion is booming worldwide. India, in particular, is seeing rapid growth thanks to state funding…
Read MoreNearly Half of Global C-Suites Plan U.S. Expansion Within 12 Months, as Supply Chain and Capital Access Drive Growth
Business Wire India • 45% of C-level executives plan to establish a U.S. legal entity within the next 12 months;…
Read MoreVenture Global and Edison Announce Calcasieu Pass Arbitration Settlement
Business Wire India Today, Venture Global and Edison jointly announced the signature of a commercial agreement for the settlement of…
Read MoreOmdia: YouTube Expected to Approach 3 Billion Global Users by 2027 as Netflix Surpasses 1 Billion
Business Wire India Netflix is forecast to reach over 1 billion monthly active users globally by 2027, while YouTube is…
Read MoreBiocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
Business Wire India Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the…
Read MoreRubedo Life Sciences Announces Positive Preliminary Phase 1 Clinical Trial Results for Lead Drug Candidate RLS-1496 in Patients with Plaque Psoriasis, Atopic Dermatitis, and Skin Aging
Business Wire India The Phase 1 study of RLS-1496, the first human trial of a GPX4 (selective glutathione peroxidase 4)…
Read More